Molecular dissection of a viral quasispecies under mutagenic treatment: Positive correlation between fitness loss and mutational load

Journal of General Virology

Volumn 94, Issue PART4, 2013, Pages 817-830

  Arias, Armando ^a,b   de Ávila, Ana Isabel ^a   Sanz Ramos, Marta ^a,c   Agudo, Rubén ^a,d   Escarmís, Cristina ^a   Domingo, Esteban ^a,e  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL MUTAGEN; RIBAVIRIN;

AMINO ACID SUBSTITUTION; ARTICLE; CLONE; CYTOPATHOLOGY; FOOT AND MOUTH DISEASE; IMMUNE RESPONSE; INTERNAL RIBOSOME ENTRY SITE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROGENY; RNA VIRUS; VIRAL CLEARANCE; VIRUS CULTURE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS TITRATION; VIRUS VIABILITY; VIRUS VIRULENCE;

EID: 84875662450     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.049171-0     Document Type: Article

References (88)

1. Agudo, R., Arias, A. & Domingo, E. (2009). 5-Fluorouracil in lethal mutagenesis of foot-and-mouth disease virus. Future Medical Chemistry 1, 529-539.
2. Agudo, R., Ferrer-Orta, C., Arias, A., de la Higuera, I., Perales, C., Pérez-Luque, R., Verdaguer, N. & Domingo, E. (2010). A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. PLoS Pathog 6, e1001072.
3. Airaksinen, A., Pariente, N., Menéndez-Arias, L. & Domingo, E. (2003). Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311, 339-349.
4. Anderson, J. P., Daifuku, R. & Loeb, L. A. (2004). Viral error catastrophe by mutagenic nucleosides. Annu Rev Microbiol 58, 183-205.
5. Arias, A., Ruiz-Jarabo, C. M., Escarmís, C. & Domingo, E. (2004). Fitness increase of memory genomes in a viral quasispecies. J Mol Biol 339, 405-412.
6. Arias, A., Agudo, R., Ferrer-Orta, C., Pérez-Luque, R., Airaksinen, A., Brocchi, E., Domingo, E., Verdaguer, N. & Escarmís, C. (2005). Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. J Mol Biol 353, 1021-1032.
7. Arias, A., Arnold, J. J., Sierra, M., Smidansky, E. D., Domingo, E. & Cameron, C. E. (2008). Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J Virol 82, 12346-12355.
8. Arnold, J. J., Vignuzzi, M., Stone, J. K., Andino, R. & Cameron, C. E. (2005). Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J Biol Chem 280, 25706-25716.
9. Asahina, Y., Izumi, N., Enomoto, N., Uchihara, M., Kurosaki, M., Onuki, Y., Nishimura, Y., Ueda, K., Tsuchiya, K. & other authors (2005). Mutagenic effects of ribavirin and response to interferon/ ribavirin combination therapy in chronic hepatitis C. J Hepatol 43, 623-629.
10. Batschelet, E., Domingo, E. & Weissmann, C. (1976). The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene 1, 27-32.
11. Bull, R. A., Eden, J. S., Rawlinson, W. D. & White, P. A. (2010). Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog 6, e1000831.
12. Carrillo, C., Tulman, E. R., Delhon, G., Lu, Z., Carreno, A., Vagnozzi, A., Kutish, G. F. & Rock, D. L. (2005). Comparative genomics of foot-and-mouth disease virus. J Virol 79, 6487-6504.
13. Castro, C., Arnold, J. J. & Cameron, C. E. (2005). Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res 107, 141-149.
14. Cencic, R., Mayer, C., Juliano, M. A., Juliano, L., Konrat, R., Kontaxis, G. & Skern, T. (2007). Investigating the substrate specificity and oligomerisation of the leader protease of foot and mouth disease virus using NMR. J Mol Biol 373, 1071-1087.
15. Chevaliez, S., Brillet, R., Lázaro, E., Hézode, C. & Pawlotsky, J. M. (2007). Analysis of ribavirin mutagenicity in human hepatitis C virus infection. J Virol 81, 7732-7741.
16. Clay, P. G., McRae, M. & Laurent, J. P. (2011). Safety, tolerability, and pharmacokinetics of KP-1461 in phase I clinical studies: a single oral dose study in non-HIV-infected adults, and a 14-day dose-escalating study in highly antiretroviral-experienced HIV-infected adults. J Int Assoc Physicians AIDS Care (Chic) 10, 232-238.
17. Contreras, A. M., Hiasa, Y., He, W., Terella, A., Schmidt, E. V. & Chung, R. T. (2002). Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol 76, 8505-8517.
18. Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y., Hong, Z., Andino, R. & Cameron, C. E. (2000). The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 6, 1375-1379.
19. Cuevas, J. M., González-Candelas, F., Moya, A. & Sanjuán, R. (2009). Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo. J Virol 83, 5760-5764.
20. de la Torre, J. C., Martínez-Salas, E., Diez, J., Villaverde, A., Gebauer, F., Rocha, E., Dávila, M. & Domingo, E. (1988). Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol 62, 2050-2058.
21. Dixit, N. M., Layden-Almer, J. E., Layden, T. J. & Perelson, A. S. (2004). Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 432, 922-924.
22. Domingo, E. (2000). Viruses at the edge of adaptation. Virology 270, 251-253.
23. Domingo, E. (2007). Virus evolution. In Fields Virology, 5th edn, pp. 389-421. Edited by D. M. Knipe & P. M. Howley. Philadelphia: LWW.
24. Domingo, E., Martin, V., Perales, C., Grande-Pérez, A., García-Arriaza, J. & Arias, A. (2006). Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol 299, 51-82.
25. Domingo, E., Sheldon, J. & Perales, C. (2012). Viral quasispecies evolution. Microbiol Mol Biol Rev 76, 159-216.
26. Drake, J. W. & Holland, J. J. (1999). Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96, 13910-13913.
27. Eigen, M. (2002). Error catastrophe and antiviral strategy. Proc Natl Acad Sci U S A 99, 13374-13376.
28. Eigen, M. & Biebricher, C. K. (1988). Sequence space and quasispecies distribution. In RNA Genetics, vol. 3., pp. 211-245. Edited by E. Domingo, P. Ahlquist & J. J. Holland. Boca Raton, FL: CRC Press.
29. Eigen, M. & Schuster, P. (1979). The Hypercycle. A Principle of Natural Self-Organization. Berlin: Springer.
30. Escarmís, C., Dávila, M., Charpentier, N., Bracho, A., Moya, A. & Domingo, E. (1996). Genetic lesions associated with Muller's ratchet in an RNA virus. J Mol Biol 264, 255-267.
31. Escarmís, C., Dávila, M. & Domingo, E. (1999). Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J Mol Biol 285, 495-505.
32. Escarmís, C., Lázaro, E. & Manrubia, S. C. (2006). Population bottlenecks in quasispecies dynamics. Curr Top Microbiol Immunol 299, 141-170.
33. Escarmís, C., Lázaro, E., Arias, A. & Domingo, E. (2008). Repeated bottleneck transfers can lead to non-cytocidal forms of a cytopathic virus: implications for viral extinction. J Mol Biol 376, 367-379.
34. Ferrer-Orta, C., Arias, A., Pérez-Luque, R., Escarmís, C., Domingo, E. & Verdaguer, N. (2007). Sequential structures provide insights into the fidelity of RNA replication. Proc Natl Acad Sci U S A 104, 9463-9468.
35. Ferrer-Orta, C., Sierra, M., Agudo, R., de la Higuera, I., Arias, A., Pérez-Luque, R., Escarmís, C., Domingo, E. & Verdaguer, N. (2010). Structure of foot-and-mouth disease virus mutant polymerases with reduced sensitivity to ribavirin. J Virol 84, 6188-6199.
36. Gnadig, N. F., Beaucourt, S., Campagnola, G., Bordería, A. V., Sanz-Ramos, M., Gong, P., Blanc, H., Peersen, O. B. & Vignuzzi, M. (2012). Coxsackievirus B3 mutator strains are attenuated in vivo. Proc Natl Acad Sci U S A 109, E2294-E2303.
37. González-López, C., Arias, A., Pariente, N., Gómez-Mariano, G. & Domingo, E. (2004). Preextinction viral RNA can interfere with infectivity. J Virol 78, 3319-3324.
38. González-López, C., Gómez-Mariano, G., Escarmís, C. & Domingo, E. (2005). Invariant aphthovirus consensus nucleotide sequence in the transition to error catastrophe. Infect Genet Evol 5, 366-374.
39. Graci, J. D. & Cameron, C. E. (2008). Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virol 3, 553-566.
40. Grande-Pérez, A., Sierra, S., Castro, M. G., Domingo, E. & Lowenstein, P. R. (2002). Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc Natl Acad Sci U S A 99, 12938-12943.
41. Grande-Pérez, A., Gómez-Mariano, G., Lowenstein, P. R. & Domingo, E. (2005a). Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J Virol 79, 10451-10459.
42. Grande-Pérez, A., Lázaro, E., Lowenstein, P., Domingo, E. & Manrubia, S. C. (2005b). Suppression of viral infectivity through lethal defection. Proc Natl Acad Sci U S A 102, 4448-4452.
43. Harris, K. S., Brabant, W., Styrchak, S., Gall, A. & Daifuku, R. (2005). KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. Antiviral Res 67, 1-9.
44. Hicks, C., Clay, P., Redfield, R. R., Lalezari, J. P., Liporace, R., Schneider, S., Sension, M., McRae, M. & Laurent, J. P. (2012). Safety, tolerability, and efficacy of KP-1461 as monotherapy for 124 days in antiretroviral-experienced, HIV type 1-infected subjects. AIDS Res Hum Retroviruses 120827084548003. (Epub ahead of print).
45. Holland, J., Spindler, K., Horodyski, F., Grabau, E., Nichol, S. & VandePol, S. (1982). Rapid evolution of RNA genomes. Science 215, 1577-1585.
46. Holland, J. J., Domingo, E., de la Torre, J. C. & Steinhauer, D. A. (1990). Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol 64, 3960-3962.
47. Kanda, T., Yokosuka, O., Imazeki, F., Tanaka, M., Shino, Y., Shimada, H., Tomonaga, T., Nomura, F., Nagao, K. & other authors (2004). Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA. J Viral Hepat 11, 479-487.
48. Lauring, A. S. & Andino, R. (2010). Quasispecies theory and the behavior of RNA viruses. PLoS Pathog 6, e1001005.
49. Lázaro, E., Escarmís, C., Pérez-Mercader, J., Manrubia, S. C. & Domingo, E. (2003). Resistance of virus to extinction on bottleneck passages: study of a decaying and fluctuating pattern of fitness loss. Proc Natl Acad Sci U S A 100, 10830-10835.
50. Levi, L. I., Gnadig, N. F., Beaucourt, S., McPherson, M. J., Baron, B., Arnold, J. J. & Vignuzzi, M. (2010). Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Pathog 6, e1001163.
51. Loeb, L. A., Essigmann, J. M., Kazazi, F., Zhang, J., Rose, K. D. & Mullins, J. I. (1999). Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A 96, 1492-1497.
52. Lutchman, G., Danehower, S., Song, B. C., Liang, T. J., Hoofnagle, J. H., Thomson, M. & Ghany, M. G. (2007). Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy. Gastroenterology 132, 1757-1766.
53. Maag, D., Castro, C., Hong, Z. & Cameron, C. E. (2001). Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J Biol Chem 276, 46094-46098.
54. Mahy, B. W. (2005). Introduction and history of foot-and-mouth disease virus. Curr Top Microbiol Immunol 288, 1-8.
55. Martín, V., Grande-Pérez, A. & Domingo, E. (2008). No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus. Virology 378, 185-192.
56. Martín, V., Abia, D., Domingo, E. & Grande-Pérez, A. (2010). An interfering activity against lymphocytic choriomeningitis virus replication associated with enhanced mutagenesis. J Gen Virol 91, 990-1003.
57. Más, A., López-Galíndez, C., Cacho, I., Gómez, J. & Martínez, M. A. (2010). Unfinished stories on viral quasispecies and Darwinian views of evolution. J Mol Biol 397, 865-877.
58. Mateo, R., Díaz, A., Baranowski, E. & Mateu, M. G. (2003). Complete alanine scanning of intersubunit interfaces in a foot-and-mouth disease virus capsid reveals critical contributions of many side chains to particle stability and viral function. J Biol Chem 278, 41019-41027.
59. McFadden, N., Bailey, D., Carrara, G., Benson, A., Chaudhry, Y., Shortland, A., Heeney, J., Yarovinsky, F., Simmonds, P. & other authors (2011). Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog 7, e1002413.
60. Moreno, H., Gallego, I., Sevilla, N., de la Torre, J. C., Domingo, E. & Martín, V. (2011). Ribavirin can be mutagenic for arenaviruses. J Virol 85, 7246-7255.
61. Moriyama, K., Suzuki, T., Negishi, K., Graci, J. D., Thompson, C. N., Cameron, C. E. & Watanabe, M. (2008). Effects of introduction of hydrophobic group on ribavirin base on mutation induction and anti-RNA viral activity. J Med Chem 51, 159-166.
62. Mullins, J. I., Heath, L., Hughes, J. P., Kicha, J., Styrchak, S., Wong, K. G., Rao, U., Hansen, A., Harris, K. S. & other authors (2011). Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461. PLoS ONE 6, e15135.
63. O'Dea, E. B., Keller, T. E. & Wilke, C. O. (2010). Does mutational robustness inhibit extinction by lethal mutagenesis in viral populations? PLOS Comput Biol 6, e1000811.
64. Parera, M., Fernàndez, G., Clotet, B. & Martínez, M. A. (2007). HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol 24, 382-387.
65. Pariente, N., Sierra, S., Lowenstein, P. R. & Domingo, E. (2001). Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J Virol 75, 9723-9730.
66. Perales, C., Mateo, R., Mateu, M. G. & Domingo, E. (2007). Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants. J Mol Biol 369, 985-1000.
67. Perales, C., Agudo, R. & Domingo, E. (2009a). Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. PLoS ONE 4, e5554.
68. Perales, C., Agudo, R., Tejero, H., Manrubia, S. C. & Domingo, E. (2009b). Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. PLoS Pathog 5, e1000658.
69. Perales, C., Lorenzo-Redondo, R., López-Galíndez, C., Martínez, M. A. & Domingo, E. (2010). Mutant spectra in virus behavior. Future Virology 5, 679-698.
70. Perales, C., Henry, M., Domingo, E., Wain-Hobson, S. & Vartanian, J. P. (2011). Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space. J Virol 85, 12227-12240.
71. Perelson, A. S. & Layden, T. J. (2007). Ribavirin: is it a mutagen for hepatitis C virus? Gastroenterology 132, 2050-2052.
72. Pfeiffer, J. K. & Kirkegaard, K. (2003). A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S A 100, 7289-7294.
73. Pfeiffer, J. K. & Kirkegaard, K. (2005). Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog 1, e11.
74. Rowlands, D. J. E. (2003). Foot-and-mouth disease. Virus Res 91, 1-161.
75. Ruiz-Jarabo, C. M., Ly, C., Domingo, E. & de la Torre, J. C. (2003). Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308, 37-47.
76. Sanjuán, R., Moya, A. & Elena, S. F. (2004). The contribution of epistasis to the architecture of fitness in an RNA virus. Proc Natl Acad Sci U S A 101, 15376-15379.
77. Sanjuán, R., Cuevas, J. M., Furió, V., Holmes, E. C. & Moya, A. (2007). Selection for robustness in mutagenized RNA viruses. PLoS Genet 3, e93.
78. Sanz-Ramos, M., Rodríguez-Calvo, T. & Sevilla, N. (2012). Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population. PLoS ONE 7, e39941.
79. Sierra, S., Dávila, M., Lowenstein, P. R. & Domingo, E. (2000). Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol 74, 8316-8323.
80. Sierra, M., Airaksinen, A., González-López, C., Agudo, R., Arias, A. & Domingo, E. (2007). Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J Virol 81, 2012-2024.
81. Sobrino, F. & Domingo, E. E. (2004). Foot-and-Mouth Disease: Current Perspectives. Wymondham, UK: Horizon Bioscience.
82. Sobrino, F., Dávila, M., Ortín, J. & Domingo, E. (1983). Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128, 310-318.
83. Sorgeloos, F., Vertommen, D., Rider, M. H. & Michiels, T. (2011). Theiler's virus L protein is targeted to the mitochondrial outer membrane. J Virol 85, 3690-3694.
84. Swetina, J. & Schuster, P. (1982). Self-replication with errors. A model for polynucleotide replication. Biophys Chem 16, 329-345.
85. Vignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E. & Andino, R. (2006). Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439, 344-348.
86. Vignuzzi, M., Wendt, E. & Andino, R. (2008). Engineering attenuated virus vaccines by controlling replication fidelity. Nat Med 14, 154-161.
87. Zhou, S., Liu, R., Baroudy, B. M., Malcolm, B. A. & Reyes, G. R. (2003). The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. Virology 310, 333-342.
88. Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31, 3406-3415.